Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis

By Aikawa NE   Campos LMA   Goldenstein-Schainberg C   Saad CGS   Ribeiro AC   Bueno C   Precioso AR   Timenetsky MdoC   Silva CAA   Bonfá E  

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 1, 2013-01 ,pp. : 34-40

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Severe Cases of Pandemic (H1N1) 2009 Influenza: Review of Antivirals and Adjuvant Therapy

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 152-156

Bentham Science Publishers

Access to resources Recommend Favorite

Epidemiology and Clinical Presentation of Pandemic Influenza A (H1N1) among Hospitalized Children in Kuwait

By  

Medical Principles and Practice, Vol. 21, Iss. 3, 2011-11 ,pp. : 254-258

Karger

Access to resources Recommend Favorite

Leptin Mediates the Pathogenesis of Severe 2009 Pandemic Influenza A(H1N1) Infection Associated With Cytokine Dysregulation in Mice With Diet-Induced Obesity

By Zhang Anna J. X.   To Kelvin K. W.   Li Can   Lau Candy C. Y.   Poon Vincent K. M.   Chan Chris C. S.   Zheng Bo-Jian   Hung Ivan F. N.   Lam Karen S. L.   Xu Aimin   Yuen Kwok-Yung  

The Journal of Infectious Diseases, Vol. 207, Iss. 8, 2013-04 ,pp. : 1270-1280

Oxford University Press

Access to resources Recommend Favorite

Effectiveness of Monovalent 2009 Pandemic Influenza A Virus Subtype H1N1 and 20102011 Trivalent Inactivated Influenza Vaccines in Wisconsin During the 20102011 Influenza Season

By Bateman Allen C.   Kieke Burney A.   Irving Stephanie A.   Meece Jennifer K.   Shay David K.   Belongia Edward A.  

The Journal of Infectious Diseases, Vol. 207, Iss. 8, 2013-04 ,pp. : 1262-1269

Oxford University Press

Access to resources Recommend Favorite